Literature DB >> 3902214

HLA class I and beta 2-microglobulin expression in frozen and formaldehyde-fixed paraffin sections of neuroblastoma tumors.

J P Whelan, J Chatten, L A Lampson.   

Abstract

Ten solid neuroblastoma tumors were examined for beta 2-microglobulin (beta 2-m) and HLA-class I expression in an immunocytochemical assay. Blood vessel endothelium and a small population of cells (less than 6% of small round cells) were consistently stained in frozen sections of each tumor. No beta 2-m or HLA-class I reactivity was detected in the remainder (greater than 94%) of the small round cells in each tumor. The localization of most of the positive cells near stromal tissue and blood vessels suggests that most of these cells may be of non-tumor origin. The patients from which the tumors were taken varied in degree of disease involvement, yet no differences with respect to beta 2-m and HLA-class I expression were found among the tumors. A procedure for visualizing beta 2-m and HLA-class I molecules in formaldehyde-fixed, paraffin-embedded tissue is described. This confirmed the results in frozen sections. These findings extend previous reports of weak beta 2-m and HLA-class I levels in cells of neuronal origin. The clinical implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902214

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Towards the phenotyping of soft tissue tumours by cell surface molecules.

Authors:  G Mechtersheimer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

2.  Macrophage-mediated anti-tumor immunity against high-risk neuroblastoma.

Authors:  Xao X Tang; Hiroyuki Shimada; Naohiko Ikegaki
Journal:  Genes Immun       Date:  2022-05-07       Impact factor: 4.248

3.  Human neuroblastoma cell growth in xenogeneic hosts: comparison of T cell-deficient and NK-deficient hosts, and subcutaneous or intravenous injection routes.

Authors:  W J Turner; J Chatten; L A Lampson
Journal:  J Neurooncol       Date:  1990-04       Impact factor: 4.130

4.  High-throughput molecular and histopathologic profiling of tumor tissue in a novel transplantable model of murine neuroblastoma: new tools for pediatric drug discovery.

Authors:  Jimmy K Stauffer; Rimas J Orentas; Erin Lincoln; Tahira Khan; Rosalba Salcedo; Julie A Hixon; Timothy C Back; Jun S Wei; Rajesh Patidar; Young Song; Laura Hurd; Maria Tsokos; Edwin W Lai; Graeme Eisenhofer; William Weiss; Javed Khan; Jon M Wigginton
Journal:  Cancer Invest       Date:  2012-06       Impact factor: 2.176

Review 5.  Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics.

Authors:  C U Louis; M K Brenner
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

6.  Clinical Relevance of CD4 Cytotoxic T Cells in High-Risk Neuroblastoma.

Authors:  Xao X Tang; Hiroyuki Shimada; Naohiko Ikegaki
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

7.  HLA expression in human hepatocellular carcinoma.

Authors:  A C Paterson; R Sciot; M C Kew; F Callea; G M Dusheiko; V J Desmet
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

8.  The effects of irradiation on major histocompatibility complex expression and lymphocytic infiltration in the normal rat brain and the 9L gliosarcoma brain tumor model.

Authors:  P Wen; J S Loeffler; J H Morris; L A Lampson
Journal:  J Neuroimmunol       Date:  1990-05       Impact factor: 3.478

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.